Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Enamel matrix derivative proteins for the treatment of proximal class II furcation involvements: a prospective 24-month randomized clinical trial

Full text
Author(s):
Viana Casarin, Renato Correa [1, 2] ; Ribeiro, Erica Del Peloso [1] ; Nociti, Jr., Francisco Humberto [1] ; Sallum, Antonio Wilson [1] ; Bovi Ambrosano, Glaucia Maria [3] ; Sallum, Enilson Antonio [1] ; Casati, Marcio Zaffalon [1]
Total Authors: 7
Affiliation:
[1] Univ Estadual Campinas, UNICAMP, Sch Dent Piracicaba, Dept Prosthodont & Periodont, Div Periodont, Sao Paulo - Brazil
[2] Univ Sao Francisco, Fac Dent, Dept Periodont, Sao Paulo - Brazil
[3] Univ Estadual Campinas, Div Bioestat, Sch Dent Piracicaba, Dept Social Dent, BR-13414903 Piracicaba, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: JOURNAL OF CLINICAL PERIODONTOLOGY; v. 37, n. 12, p. 1100-1109, DEC 2010.
Web of Science Citations: 18
Abstract

P>Objective This study aimed to evaluate the response of proximal furcations treated with enamel matrix derivative proteins (EMD) in a 24-month follow-up. Materials and Methods Twelve patients presenting bilateral class II proximal furcation with vertical probing depth (PD)>= 5 mm and bleeding on probing were selected. The furcations were assigned to: a control group (n=12), open flap debridement (OFD)+EDTA and a test group (n=12) - OFD+EDTA+EMD. The gingival margin position, PD, relative vertical and horizontal clinical attachment level (RVCAL and RHCAL), vertical and horizontal bone level (VBL and HBL) and furcation closure were evaluated before treatment and after 6, 12 and 24 months. Results After follow-up, no statistical difference could be seen between groups. At 24 months, the test group showed 1.9 +/- 1.6 mm PD reduction whereas the control group showed 1.0 +/- 1.3 mm PD reduction. RHCAL gains of the control and the test group were 0.7 +/- 1.3 and 1.4 +/- 0.9 mm, respectively. However, at 24 months, the test group only presented five remaining class II furcations versus 10 furcations in the control group (p < 0.05). Conclusion It could be concluded that EMD therapy promoted a reduction in the number of proximal furcations presenting a diagnosis of class II after 24 months of treatment compared with OFD therapy. (AU)